Analyst Ratings for Astrana Health, Inc (ASTH)
ASTH Rating Summary
ASTH Price Target Summary
- Highest: $55.00 (Truist Securities)
- Lowest: $37.00 (Jefferies)
- Average: $47.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.71 (+29.6%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$47.71 (+29.6%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | Oppenheimer | Michael Wiederhorn | New Coverage | Outperform (N/A) |
53.00 (N/A) |
39.60 (36.81) |
-7.05% | Details |
| 5/26/2026 | Barclays » Updated 8/7/2026 |
Andrew Mok | Upgrade | Overweight (Equalweight) |
53.00 (50.00) |
37.85 (36.81) |
-2.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
